Is Rockwell Medical (RMTI) Heading Towards $2 Mark?

On Thursday Rockwell Medical (NASDAQ: RMTI) plunged by 32.54% to $0.2158 while the red market was encouraging the masses to withdraw all the funds. But temporary relief in the form of a little surge in the stock market gives many emotional investors come back but the “black swan” isn’t going to leave this month.

21 hours ago Rockwell Medical has announced that it provided the FDA with the supplemental data that can add additional strength to win the approval for Ferric Pyrophosphate Citrate (FPC) from the IND (Investigational New Drug) application.

Seeing this update the demand for RMTI shares has gone mad by pushing them to rocket by 780% in premarket. Hopefully, the stock is ready to ride over $2. The new drug may push the company to new levels.

rmti stock